Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
Steinauer N, McCullough K, Al-Kali A, Alkhateeb HB, Begna KH, Mangaonkar AA, Saliba AN, Torghabeh M, Litzow MR, Hogan WJ, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Yi CA, Tefferi A, Gangat N.
Steinauer N, et al. Among authors: al kali a.
Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.284962. Online ahead of print.
Haematologica. 2024.
PMID: 38546692
Free article.